Early research (Phase 1)Study completedNCT02281474
What this trial is testing
Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
Who this might be right for
Parkinson's DiseaseParkinson's Disease DementiaDiffuse Lewy Body Disease
Georgetown University 12